EWA
LNAI

EverSource Wealth Advisors’s Lunai Bioworks LNAI Stock Holding History

EverSource Wealth Advisors’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$7 – 4413
2025
Q3 		$7 Sell
1
-5
-83% -$96 ﹤0.01% 4313
2025
Q2 		$132 Buy
+6
New +$168 ﹤0.01% 4095
2025
Q1 		– Hold
0
– – – 3984

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

EverSource Wealth Advisors's LNAI Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of Lunai Bioworks (LNAI) in Q4 2025, closing a stake of 1 share — an estimated $7 sold.

EverSource Wealth Advisors first reported a position in LNAI in Q2 2025 and held it in 2 quarters. The position peaked at $132 in Q2 2025. 22 funds tracked by Wall St. Rank hold LNAI as of Q4 2025.

  • EverSource Wealth Advisors reported no remaining Lunai Bioworks position as of Q4 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 1 Lunai Bioworks share in Q4 2025, an estimated $7.
  • EverSource Wealth Advisors first reported a position in Lunai Bioworks in Q2 2025 and held it in 2 quarters.
  • EverSource Wealth Advisors's Lunai Bioworks position peaked at $132 in Q2 2025.
  • 22 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.